NOR-1: a nitric oxide releasing agent for calibrating low levels of nitric oxide by the chemiluminescence method

被引:6
作者
Ueki, Y
Nakamura, H
Matsumoto, K
Tominaga, T
Miyake, S
Kita, Y
Katayama, Y
Fukuyama, S
Hirasawa, Y
Yoshida, K
Eguchi, K
机构
[1] Sasebo Chuo Hosp, Dept Internal Med, Sasebo 8571195, Japan
[2] Fujisawa Pharmaceut Co Ltd, New Drug Res Labs, Dept Pharmacol, Osaka 532, Japan
[3] Kyushu Univ, Sch Med, Dept Chem Sci & Technol, Fukuoka, Japan
[4] Nagasaki Univ, Sch Med, Dept Internal Med 1, Nagasaki, Japan
关键词
nitric oxide; chemiluminescent assay; nitric oxide assay; NOR-1;
D O I
10.1097/00001721-200203000-00001
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Nitric oxide (NO) is formed in small amounts in vivo and is rapidly oxidized by interacting with oxygen, making measurement of its level difficult. The chemiluminescence assay is the most widely used method for detecting NO and is extremely sensitive to very small amounts of NO. However, it is difficult to prepare small amounts of NO to be used as a standard for NO analysis. NOR-1, a derivative of NOR-3, is a newly discovered NO donor with rapid NO-releasing activity. We assessed the dynamics of NO release and decomposition using NOR-1. Our results demonstrate that NOR-1 is stable in dimethylsulfoxide (DMSO) and is able to dilute at lower concentration (to picomolar levels) by DMSO without decomposition. NOR-1 released persistently 1.4 more excess of NO with 15 min of incubation. There was a linear relationship between the concentration of NOR-1 and that of NO released from NOR-1 (r = 0.997) These findings suggest that NOR-1 is a useful reagent for the calibration of lower NO detection. Blood Coagul Fibrinolysis 13:75-80 (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 26 条
[1]
ANTAGONISTIC ACTION OF IMIDAZOLINEOXYL N-OXIDES AGAINST ENDOTHELIUM-DERIVED RELAXING FACTOR .NO THROUGH A RADICAL REACTION [J].
AKAIKE, T ;
YOSHIDA, M ;
MIYAMOTO, Y ;
SATO, K ;
KOHNO, M ;
SASAMOTO, K ;
MIYAZAKI, K ;
UEDA, S ;
MAEDA, H .
BIOCHEMISTRY, 1993, 32 (03) :827-832
[2]
[Anonymous], IMMUNOLOGY TODAY
[3]
MEASUREMENT OF NITRIC-OXIDE IN BIOLOGICAL MODELS [J].
ARCHER, S .
FASEB JOURNAL, 1993, 7 (02) :349-360
[4]
Az-Ma Toshiharu, 1994, Life Sciences, V54, P185
[5]
NANOGRAM NITRITE AND NITRATE DETERMINATION IN ENVIRONMENTAL AND BIOLOGICAL-MATERIALS BY VANADIUM(III) REDUCTION WITH CHEMI-LUMINESCENCE DETECTION [J].
BRAMAN, RS ;
HENDRIX, SA .
ANALYTICAL CHEMISTRY, 1989, 61 (24) :2715-2718
[6]
QUANTITATION OF NITRIC-OXIDE FORMATION FROM NITROVASODILATOR DRUGS BY CHEMILUMINESCENCE ANALYSIS OF HEADSPACE GAS [J].
BRIEN, JF ;
MCLAUGHLIN, BE ;
NAKATSU, K ;
MARKS, GS .
JOURNAL OF PHARMACOLOGICAL METHODS, 1991, 25 (01) :19-27
[7]
CHUNG SJ, 1990, J PHARMACOL EXP THER, V253, P614
[9]
NITRIC-OXIDE (NO) FORMATION FROM NITROVASODILATORS OCCURS INDEPENDENTLY OF HEMOGLOBIN OR NONHEME IRON [J].
FEELISCH, M ;
NOACK, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 142 (03) :465-469
[10]
CORRELATION BETWEEN NITRIC-OXIDE FORMATION DURING DEGRADATION OF ORGANIC NITRATES AND ACTIVATION OF GUANYLATE-CYCLASE [J].
FEELISCH, M ;
NOACK, EA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (01) :19-30